Yen-Jen Wang
Overview
    Explore the profile of Yen-Jen Wang including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              31
            
            
              Citations
              90
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Wu B, Wang Y, Chang C, Juang T, Huang Y, Hsu Y
  
  
    J Clin Med
    . 2024 Dec;
          13(23).
    
    PMID: 39685940
  
  
           Melasma is a challenging, acquired hyperpigmentary disorder. The gold standard treatment is Kligman's formulation, which contains hydroquinone, tretinoin, and dexamethasone, but its long-term use is limited by the risk of...
      
2.
        
    
    Chang H, Wu B, Chang C, Chen Y, Wang Y
  
  
    Lasers Surg Med
    . 2024 Sep;
          57(1):71-79.
    
    PMID: 39308037
  
  
          Objectives: This retrospective study evaluates the effectiveness of pulsed dye laser (PDL) treatment in early versus late treatment groups for traumatic or postoperative scars. The study aims to determine the...
      
3.
        
    
    Lin Y, Wu B, Chang C, Huang Y, Wang Y
  
  
    Lasers Med Sci
    . 2024 Aug;
          39(1):216.
    
    PMID: 39141143
  
  
          This brief report discusses the challenges in treating dermal melanosis and the limitations of current laser treatments due to inadequate tissue penetration and potential side effects. It introduces laser-induced optical...
      
4.
        
    
    Chang C, Wang Y, Huang L, Chen I, Shih Y, Shen J, et al.
  
  
    J Eur Acad Dermatol Venereol
    . 2024 Mar;
          38(10):e870-e873.
    
    PMID: 38511971
  
  
          No abstract available.
      
5.
        
    
    Liao Y, Chu C, Hui C, Li C, Lin S, Tseng H, et al.
  
  
    J Formos Med Assoc
    . 2023 Dec;
          123(12):1228-1238.
    
    PMID: 38160191
  
  
          Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disease characterized by painful, recurrent, inflamed lesions most commonly occurring in the axillary, inguinal, and anogenital regions. HS can inflict immense physical...
      
6.
        
    
    Wang Y, Chang C, Wu Y, Huang L, Shen J, Lu M, et al.
  
  
    Lasers Surg Med
    . 2023 Jun;
          55(7):680-689.
    
    PMID: 37365922
  
  
          Background: Dynamic in vivo changes in melanin in melasma lesions after exposure to ultraviolet (UV) irradiation have not been described. Objectives: To determine whether melasma lesions and nearby perilesions demonstrated...
      
7.
        
    
    Wang Y, Chang C, Lu M, Wu Y, Shen J, Chiang H, et al.
  
  
    Int J Mol Sci
    . 2022 Jul;
          23(13).
    
    PMID: 35806013
  
  
          Although nude mice are an ideal photoaging research model, skin biopsies result in inflammation and are rarely performed at baseline. Meanwhile, studies on antiphotoaging antioxidants or rejuvenation techniques often neglect...
      
8.
        
    A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration
  
  
    
    Huang W, Cheng F, Chen C, Kuo P, Wang Y, Yin S, et al.
  
  
    Transl Vis Sci Technol
    . 2021 Dec;
          10(14):23.
    
    PMID: 34932116
  
  
          Purpose: Drug delivery to posterior ocular tissues via topical eye drop administration is arduous due to the unique anatomy and physiology of the eye. Therefore, treatments for posterior eye disease...
      
9.
        
    
    Chen Y, Lin W, Huang Y, Ho W, Fu C, Tu C, et al.
  
  
    Invest Ophthalmol Vis Sci
    . 2021 Oct;
          62(13):12.
    
    PMID: 34661609
  
  
          Purpose: The purpose of this study was to develop a preclinical compound, ITRI-E-(S)4046, a dual synergistic inhibitor of myosin light chain kinase 4 (MYLK4) and Rho-related protein kinase (ROCK), for...
      
10.
        
    
    Chen I, Wang Y, Chang C, Wu Y, Lu C, Shen J, et al.
  
  
    Diagnostics (Basel)
    . 2021 Aug;
          11(8).
    
    PMID: 34441432
  
  
          Dark skin-type individuals have a greater tendency to have pigmentary disorders, among which melasma is especially refractory to treat and often recurs. Objective measurement of melanin amount helps evaluate the...